Isoleucine

Isoleucine

SCHEMBL138093

CC[C@H](C)[C@H](N)C(=O)O.O=C(O)[C@@H]1CCCN1.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Isoleucine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 12/20 0.40
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
DPP8 Q6V1X1 4/20 0.38
DPP9 Q86TI2 4/20 0.38
DPP7 Q9UHL4 3/20 0.38
FAP Q12884 2/20 0.38
PRCP P42785 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoleucine SCHEMBL5017800 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL28231733 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL703839 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL138092 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL1537461 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL1537458 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL1537322 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL1537321 1.00 DPP4 (0.40) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL6535295 0.97 DPP4 (0.39) DPP4NOS2NOS3NOS1DPP8
Isoleucine SCHEMBL3692760 0.97 DPP4 (0.39) DPP4NOS2NOS3NOS1DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
US-11272717-B2 Edible water-in-oil emulsion and a process for preparing such emulsion Upfield Europe B.V. (NL) 2022-03-15 US claimed
EP-3134105-B1 PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) TXP PHARMA GMBH (CH) 2020-11-18 EP claimed
EP-2900206-B1 USE OF A COMBINATION OF AT LEAST ONE POLYUNSATURATED FATTY ACID AND AT LEAST ONE CAROTENOID, FOR IMPROVING THE QUALITY OF THE NAILS NUTRICOS TECH (FR) 2019-07-31 EP claimed
US-9642786-B2 Use of a combination of at least one polyunsaturated fatty acid and at least one carotenoid, for improving the quality of the nails NUTRICOS TECHNOLOGIES (FR) 2017-05-09 US claimed
US-20150250691-A1 USE OF A COMBINATION OF AT LEAST ONE POLYUNSATURATED FATTY ACID AND AT LEAST ONE CAROTENOID, FOR IMPROVING THE QUALITY OF THE NAILS NUTRICOS TECHNOLOGIES (FR) 2015-09-10 US claimed
US-20150208683-A1 EDIBLE WATER-IN-OIL EMULSION AND A PROCESS FOR PREPARING SUCH EMULSION CONOPCO, INC., D/B/A UNILEVER (US) 2015-07-30 US claimed
EP-2482678-B1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD (FI) 2013-07-10 EP claimed
EP-2482678-A1 CHEESE AND METHOD FOR ITS MANUFACTURING Valio Ltd. (FI) 2012-08-08 EP claimed
US-20120183644-A1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD. (FI) 2012-07-19 US claimed
EP-2398335-A1 PROCESS FOR IMPROVING TASTE OF FOOD PRODUCT Valio Ltd. (FI) 2011-12-28 EP claimed
WO-2011039414-A1 CHEESE AND METHOD FOR ITS MANUFACTURING VALIO LTD (FI) 2011-04-07 WO claimed
WO-2010094839-A1 PROCESS FOR IMPROVING TASTE OF FOOD PRODUCT VALIO LTD (FI) 2010-08-26 WO claimed
WO-2010023364-A1 PROCESS FOR IMPROVING TASTE OF PRODUCT VALIO LTD (FI) 2010-03-04 WO claimed
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO disclosed
EP-3995139-B1 COMPOSITION FOR USE IN TREATING CANCER UNIV GEORGIA STATE RES FOUND (US) 2026-02-18 EP disclosed
EP-4097145-B1 REDUCTION OF ADSORPTION LEUKOCARE AG (DE) 2026-01-28 EP disclosed
US-20090298773-A1 METHODS OF PRODUCING FUNCTIONAL MISO MARUKOME CO., LTD. (JP) 2009-12-03 US disclosed
EP-1485119-A1 ENHANCING THE AVAILABILITY OF MINERALS BY USING BIOLOGICALLY ACTIVE PEPTIDES Valio Ltd. (FI) 2004-12-15 EP disclosed
WO-2003070267-A1 ENHANCING THE AVAILABILITY OF MINERALS BY USING BIOLOGICALLY ACTIVE PEPTIDES VALIO LTD (FI) 2003-08-28 WO disclosed